Skip to main content
. 2016 Jul 7;36(10):837–848. doi: 10.1007/s40261-016-0435-6

Table 5.

Comparison of baseline activated clotting times (ACTs) between patients who underwent atrial fibrillation (AF) ablation in the morning or afternoon

N AF ablation time P value
Morning Afternoon
N ACT (s) N ACT (s)
All 360 148 141 ± 18 212 145 ± 18 0.06
Warfarin 90 40 152 ± 16 50 151 ± 18 0.74
Dabigatran 90 22 153 ± 13 68 157 ± 16 0.28
Rivaroxaban 90 40 134 ± 13 50 135 ± 11 0.58
Apixaban  90 46 133 ± 20 44 132 ± 14 0.79

Values are presented as mean ± standard deviation